Blincyto

(blinatumomab)
blinatumomab 0.035 MG Injection [Blincyto]

Dosage & administration

biomarker testing

Blincyto clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Blincyto prescribing information

prior authorization

Blincyto prior authorization resources

PDF
Complete Letter of Medical Necessity

PDF
Coverage Authorization Appeals
Learn More

Benefits investigation

PDF
Benefits Verification
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

financial assistance

Blincyto financial assistance options

Co-pay savings program

commercial only
Enroll in Patient Savings Program
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+

OTHER
Amgen Safety Net Foundation Patient Assistance Program
Learn More

patient education

Blincyto patient education

Getting started on Blincyto

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

BRAND PAGE
About Blincyto: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
About Blincyto (Pediatrics): Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Receiving Blincyto: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
About Blincyto: Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
About Blincyto (Pediatrics): Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Receiving Treatment: Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Patient Resources: Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Brochure : Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Brochure: Minimal Residual Disease (+) ALL - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Pediatric Patient Brochure: Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Pediatric Patient Brochure: Minimal Residual Disease (+) ALL - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Medication Information Card: Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Medical Information Card: Minimal Residual Disease (+) ALL - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Patient Resources: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Brochure: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Brochure: Relapsed or Refractory CD19-positive B-cell Precursor ALL - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Pediatric Patient Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Pediatric Patient Brochure: Relapsed or Refractory CD19-positive B-cell Precursor ALL - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Medical Information Card: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Learn More

people also ask

Blincyto FAQs

How is the dosage of Blincyto?Blincyto is available in 1 dosages, including 35 mcg Injection
What does Blincyto treat?Blincyto treats Lymphoid Leukemia
What is Blincyto made of?Blincyto contains blinatumomab which is a Bispecific CD19-directed CD3-directed T Cell Engager
How Is Blincyto Administered?Blincyto is administered as a Injectable
What Are The Blincyto Mechanism Of Action?Blincyto mechanism of action is CD19-directed Antibody Interactions, CD3 Receptor Agonists or CD3-directed Antibody Interactions
FAQ Data Source